{
    "2019-03-27": [
        [
            {
                "time": "2019-03-27",
                "original_text": "Pfizer (PFE) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "Calithera (CALA) Initiates Phase I/II Study of Telaglenastat",
                "features": {
                    "keywords": [
                        "Calithera",
                        "Phase I/II",
                        "Telaglenastat"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "After Hours Most Active for Mar 27, 2019 : TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI",
                "features": {
                    "keywords": [
                        "Most Active",
                        "After Hours",
                        "PFE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "6 Stocks With High Dividend Yields",
                "features": {
                    "keywords": [
                        "High Dividend Yields",
                        "Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "6 Gene Therapy M&A Targets On The Radar",
                "features": {
                    "keywords": [
                        "Gene Therapy",
                        "M&A Targets"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Pipeline",
                        "Promise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}